Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells

Resistance to apoptosis underpins the corticosteroid insensitivity of group 2 innate lymphoid cells

CAPSULE SUMMARY: Out of all type-2 immune cells, only ILC2s withstand corticosteroid treatment due to a reduced pro-apoptotic machinery. The findings may advance the understanding on the mechanism in steroid-resistant diseases and facilitate the development of improved therapies.

Bibliografiset tiedot
Päätekijät:	Luo, J, Wu, Y, Shrimanker, R, Go, S, Ye, Y, Hardman, C, Nahler, J, Chen, Y, Stöger, L, Zeng, N, Liu, W, Reed, L, Tolkovsky, A, Klenerman, P, Ogg, G, Pavord, I, Xue, L
Aineistotyyppi:	Journal article
Kieli:	English
Julkaistu:	Elsevier 2019

Samankaltaisia teoksia

Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
Tekijä: Hardman, C, et al.
Julkaistu: (2019)

Investigating functions of human group 2 innate lymphoid cells in health and disease
Tekijä: Nahler, J
Julkaistu: (2021)

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent
Tekijä: Hardman, CS, et al.
Julkaistu: (2021)

Cytometric gating stringency impacts on studies of type 2 innate lymphoid cells in asthma
Tekijä: Hinks, T, et al.
Julkaistu: (2017)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Tekijä: Chen, W, et al.
Julkaistu: (2018)

Effects of steroids in cultured human type-2 cytokine producing cells
Tekijä: Luo, J, et al.
Julkaistu: (2018)

Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
Tekijä: Sandham, D, et al.
Julkaistu: (2019)

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells
Tekijä: Hardman, C, et al.
Julkaistu: (2017)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
Tekijä: Ogg, G, et al.
Julkaistu: (2015)

Group 2 innate lymphoid cells express functional NKp30 receptor inducing type 2 cytokine production
Tekijä: Salimi, M, et al.
Julkaistu: (2015)

The effect of oral corticosteroids on circulating type-2 cytokine producing cells in patients with severe eosinophilic asthma
Tekijä: Hynes, G, et al.
Julkaistu: (2018)

Oxidative Stress Promotes Corticosteroid Insensitivity in Asthma and COPD
Tekijä: Brandon W. Lewis, et al.
Julkaistu: (2021-08-01)

Group 3 innate lymphoid cells secret neutrophil chemoattractants and are insensitive to glucocorticoid via aberrant GR phosphorylation
Tekijä: Li Xiu He, et al.
Julkaistu: (2023-03-01)

Activated innate lymphoid cell populations accumulate in human tumour tissues
Tekijä: Salimi, M, et al.
Julkaistu: (2018)

Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
Tekijä: Xue, L, et al.
Julkaistu: (2018)

The role of type 2 innate lymphoid cells in the pathogenesis of atopic dermatitis
Tekijä: Salimi, M, et al.
Julkaistu: (2014)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells
Tekijä: Xue, L, et al.
Julkaistu: (2013)

Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells.
Tekijä: Xue, L, et al.
Julkaistu: (2014)

Interaction and immune regulations of innate lymphoid cells and plasmacytoid dendritic cells in skin inflammatory diseases
Tekijä: Chen, Y-L
Julkaistu: (2018)

Lymphoid microenvironments and innate lymphoid cells in the gut.
Tekijä: Pearson, C, et al.
Julkaistu: (2012)

Lymphoid microenvironments and innate lymphoid cells in the gut
Tekijä: Pearson, C, et al.
Julkaistu: (2012)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
Tekijä: Xie T, et al.
Julkaistu: (2023-05-01)

Inhibition of asthma relevant innate and adaptive human immune cells by epithelial cells
Tekijä: Powell, T, et al.
Julkaistu: (2016)

T lymphocyte insensitivity to corticosteroids in chronic obstructive pulmonary disease
Tekijä: Kaur Manminder, et al.
Julkaistu: (2012-03-01)

Innate lymphoid cells in neuroinflammation
Tekijä: Daria Kveštak, et al.
Julkaistu: (2024-02-01)

Epigenomic Views of Innate Lymphoid Cells
Tekijä: Giuseppe Sciumè, et al.
Julkaistu: (2017-11-01)

Transcriptional regulation of innate lymphoid cells and T cells by aryl hydrocarbon receptor
Tekijä: Eric Y. Helm, et al.
Julkaistu: (2023-03-01)

Activated innate lymphoid cell populations accumulate in human tumour tissues
Tekijä: Maryam Salimi, et al.
Julkaistu: (2018-03-01)

FeNO non-suppression identifies corticosteroid-resistant type-2 signaling in severe asthma
Tekijä: Couillard, S, et al.
Julkaistu: (2021)

Defects of protein phosphatase 2A causes corticosteroid insensitivity in severe asthma.
Tekijä: Yoshiki Kobayashi, et al.
Julkaistu: (2011-01-01)

The Role of Innate Lymphoid Cells in Chronic Respiratory Diseases
Tekijä: Amy T. Hsu, et al.
Julkaistu: (2021-09-01)

Common-Lymphoid-Progenitor-Independent Pathways of Innate and T Lymphocyte Development
Tekijä: Maryam Ghaedi, et al.
Julkaistu: (2016-04-01)

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.
Tekijä: Salimi, M, et al.
Julkaistu: (2013)

Innate lymphoid cells in intestinal inflammation
Tekijä: Geremia, A, et al.
Julkaistu: (2017)

Innate lymphoid cells in models of IBD
Tekijä: Pearson, C, et al.
Julkaistu: (2012)

Innate lymphoid cells and infectious diseases
Tekijä: Ting Yuan, et al.
Julkaistu: (2024-08-01)

Plasticity of Innate Lymphoid Cells in Cancer
Tekijä: Bernd Heinrich, et al.
Julkaistu: (2022-05-01)

Immunoregulatory functions of innate lymphoid cells
Tekijä: Sarah Q. Crome, et al.
Julkaistu: (2018-11-01)

Innate Lymphoid Cells in Mucosal Immunity
Tekijä: Santosh K. Panda, et al.
Julkaistu: (2019-05-01)

Innate Lymphoid Cells and Myocardial Infarction
Tekijä: Wenling Yang, et al.
Julkaistu: (2021-11-01)